News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 19453
- Sources here
- 20
- Companies here
- 36
Active search
19453 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Zacks Investment Ideas feature highlights: Applied Optoelectronics, NVIDIA and Amazon
For Immediate Release Chicago, IL – August 17, 2026 – Today, Zacks Investment Ideas feature highlights Applied Optoelectronics AAOI, NVIDIA NVDA and Amazon AMZN. The Optical Shift: Why AAOI is Built for the AI Boom Applied Optoelectronics Company Overview Zacks Rank #3 (Hold) stock …
Market Chatter: Apple May Buy Chinese Memory Chips Despite US Request
Apple (AAPL) may defy a request by the Trump administration and buy memory chips from China, which it is already testing, the Wall Street Journal reported Friday, citing people familiar with the matter. US Commerce Secretary Howard Lutnick was cited by the Journal as …
Form 8.5 (EPT/RI)--Gooch & Housego plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree …
AstraZeneca ditches lung cancer treatment trial
Drug giant AstraZeneca has revealed its latest setback in just over a month after halting a late stage lung cancer treatment trial. The FTSE 100 firm said it found its Volrustomig drug, when combined with chemotherapy, was unlikely to boost survival rates for lung …
AstraZeneca halts eVOLVE-Lung02 trial of volrustomig combo
[A big sign with AstraZeneca logotype outside the entrance.] Wirestock * AstraZeneca (AZN [https://seekingalpha.com/symbol/AZN]) is discontinuing its eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer after an independent committee concluded the drug was unlikely to meet either primary …
Ross Gerber Says 'Now Is a Good Time' to Buy iPhone 17 as Apple Prepares for Potential Price Hike With Next Model: 'If You're Looking…'
Ross Gerber, co-founder of Gerber Kawasaki Wealth & Investment Management, advises consumers to consider buying the iPhone 17 now, as Apple is expected to increase prices for future models due to rising memory costs. He noted that iPhone sales remain strong despite existing higher …
Soft Q2 2026 Results Might Change The Case For Investing In Leggett & Platt (LEG)
Leggett & Platt reported soft Q2 2026 results with lower sales and net income compared to the previous year, impacting its investment narrative. The company's weaker performance in the first half of 2026, combined with the withdrawal of 2026 guidance, intensifies focus on demand …
Applied Materials (AMAT) Could Be 19% Undervalued On Record Results And New Guidance
Applied Materials (AMAT) shares recently experienced a 5% pullback after reporting strong fiscal third-quarter results and providing robust fourth-quarter revenue guidance, despite the initial stock reaction. The company is considered 19.2% undervalued by a key narrative, with a fair value of $627.66 per share …
Michigan lawsuit alleges Apple has failed to "adequately protect" people from being stalked with AirTags
A lawsuit filed in Michigan alleges that Apple has not adequately protected individuals from being stalked using AirTags. The suit, brought by two Southeast Michigan residents, claims Apple was aware of the potential for misuse when the product launched in 2021 and that it …
Stocks making big moves this week: Applied Digital, EnerSys, Sabre, Corning, and HighPeak Energy
Stocks making big moves this week: Applied Digital, EnerSys, Sabre, Corning, and HighPeak Energy Check out the companies making headlines this week: Is now the time to buy Applied Digital? Access our full analysis report here, it's free. EnerSys (NYSE:ENS): Battery manufacturer EnerSys (NYSE:ENS) …
Short Interest in Direxion Daily META Bull 2X Shares (NASDAQ:METU) Rises By 84.0%
Short interest in Direxion Daily META Bull 2X Shares (NASDAQ:METU) increased by 84.0% in July, reaching 7.90 million shares, which represents 45.4% of shares outstanding. The leveraged ETF, which provides twice the daily exposure to Meta Platforms' stock, trades below its 52-week high and …
Precision Trading with Invesco Electric Vehicle Metals Commodity Strategy No K-1 Etf (EVMT) Risk Zones
This article provides a detailed analysis of Invesco Electric Vehicle Metals Commodity Strategy No K-1 Etf (EVMT), identifying neutral near- and mid-term readings and potential downside risk. It outlines institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis …